Barry G. W. Arnason, MD, University of Manitoba
Affiliations: | Neurology | University of Chicago, Chicago, IL |
Area:
immune cell function in multiple sclerosisWebsite:
http://neurology.uchicago.edu/Person.aspx?PersonID=1Google:
"Barry G. W. Arnason"Bio:
http://legacy.library.ucsf.edu/documentStore/i/u/s/ius46d00/Sius46d00.pdf
Mean distance: 22.01 | S | N | B | C | P |
Children
Sign in to add trainee| Jack P. Antel | grad student | Chicago (Cell Biology Tree) | |
| Daniel B. Hier | grad student | Harvard Medical School - Massachusetts General Hospital (E-Tree) | |
| Anne I Boullerne | post-doc | Chicago Medical School | |
| Howard L. Weiner | post-doc | 1972-1974 | MGH |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Buck D, Andlauer TF, Igl W, et al. (2018) Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518763089 |
| Fitzgerald KC, Munger KL, Köchert K, et al. (2015) Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. Jama Neurology. 1-8 |
| Hartung HP, Kappos L, Goodin DS, et al. (2015) Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. Journal of Neurology |
| Hartung HP, Kieseier B, Goodin DS, et al. (2012) Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies. Journal of Neuroinflammation. 9: 129 |
| Goodin DS, Hartung HP, O'Connor P, et al. (2012) Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 181-95 |
| Hartung H, Kappos L, Goodin D, et al. (2012) Predictors of Disease Activity in 857 MS Patients Treated with IFNB-1b (PD5.009) Neurology. 78 |
| Jensen M, Reder A, Niewold T, et al. (2012) Characterization of Blood-Derived Plasmacytoid Dendritic Cells and Myeloid Dendritic Cells in Multiple Sclerosis (MS) Patients, Healthy Controls, and Systemic Lupus Erythematosus (SLE) Patients (P02.101) Neurology. 78: P02.101-P02.101 |
| Patsopoulos NA, et al. (2011) Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of Neurology. 70: 897-912 |
| Acaster S, Swinburn P, Wang C, et al. (2011) Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1504-13 |
| Othman A, Frim DM, Polak P, et al. (2011) Olig1 is expressed in human oligodendrocytes during maturation and regeneration. Glia. 59: 914-26 |